Purpose: Focal cortical dysplasia (FCD) is the major cause of focal intractable epilepsy in childhood. Here we analyze the factors influencing the success of surgical treatment in a large cohort of children with histologically ascertained FCD. Method: A retrospective study of the effects of FCD type, surgical intervention, and age at surgery in a pediatric cohort. Results: A total of 113 patients (71 male; mean age at surgery 10.3 years; range 0-18) were analyzed; 45 had undergone lesionectomy, 42 lobectomy, 18 multi-lobectomy, and eight hemispherotomy. Complete seizure control (Engel Ia) was achieved in 56% after two years, 52% at five years, and 50% at last follow-up (18-204 months). Resections were more extensive in younger patients (40% of the surgeries affecting more than one lobe in patients aged nine years or younger vs. 22% in patients older than nine years). While resections were more limited in older children, their long-term outcome tended to be superior (42% seizure freedom in patients aged nine years or younger vs. 56% in patients older than nine years). The outcome in FCD I was not significantly inferior to that in FCD II. Conclusions: Our data confirm the long-term efficacy of surgery in children with FCD and epilepsy. An earlier age at surgery within this cohort did not predict a better long-term outcome, but it involved less-tailored surgical approaches. The data suggest that in patients with an unclear extent of the dysplastic area, later resections may offer advantages in terms of the precision of surgical-resection planning.
Introduction
Focal cortical dysplasia (FCD) is a subgroup of cortical malformations characterized by abnormal regional neuronal migration and differentiation that result in aberrant cortical organization [1] . It is the most common anatomo-pathological feature in patients undergoing epilepsy surgery in childhood [2] . Prevalence figures have been rising over recent years due to improved MRI quality, but, even with the best methodology currently available, the sensitivity and specificity of imaging findings are limited and a diagnosis of FCD requires histological confirmation. Patients with FCD frequently present with a severe form of epilepsy characterized by pharmacoresistance to available antiepileptic drugs (AED) [3, 4] . Surgery is considered to be of particular importance in children who-aside from seizures-may suffer from progressive developmental delay and behavioral disorders if their epilepsy is not controlled.
Several classification schemes have been proposed that rely on pathological characteristics. According to Palmini et al. [5] , two main T types of FCD can be histopathologically distinguished: Type I refers to architectural disturbances of cortical lamination (IA without, IB with giant or immature pyramidal neurons outside layer 5); Type II is characterized by dyslamination and the presence of abnormal cell elements (IIA when dysmorphic neurons are present and IIB when eosinophilic balloon cells are also identified). Particularly, giant and dysmorphic neurons are considered responsible for seizure generation in FCD Type II [6] [7] [8] [9] . In 2011, the International League Against Epilepsy (ILAE) classified FCDs in a three-tiered system that additionally distinguished whether pathological findings of FCD are isolated or associated with other epileptogenic lesions [10] .
Due to the therapeutic challenge that these patients represent, epilepsy surgery has been increasingly used in recent years, with several reports showing the benefits of the surgical treatment in patients with FCD [3, [11] [12] [13] [14] . The reported postsurgical outcome in FCD patients has, however, often been inferior to that in patients with other etiologies [15, 16] . Still, progress in presurgical assessment has improved the outcome of the surgery at increasingly early ages [17, 18] . Surgery has been found to be more effective in patients younger than 18 years compared to adults [19] and when performed in centers with extensive experience [20] . Even in patients younger than six months, surgery is considered a safe option [21] .
We analyzed possible associations between age at surgery, type of resection, FCD type (classified according to Palmini et al. [5] ), and long-term outcomes in one of the largest cohorts of patients with manifestation and surgery during childhood and with histologically confirmed FCD.
Methods

Patient selection
Patients with structural epilepsy due to FCD who were undergoing surgical treatment were identified from electronic charts. The inclusion criteria were: (1) age at surgery younger than 18 years; (2) epilepsy diagnosis confirmed by video-EEG monitoring; (3) surgical treatment at the University Hospital in Freiburg between 1999 and 2015; (4) histological confirmation of FCD based on resected specimens; and (5) clinical follow-up of at least 18 months.
Patients underwent presurgical evaluation, including long-term video-EEG recordings of habitual seizures, at the Epilepsy Centers of Kiel, Heidelberg, Kehl-Kork, and Freiburg and were later referred to the University Hospital of Freiburg for intracranial EEG recordings (if required) and surgical treatment. Individualized surgical approaches were selected depending on patient characteristics, with particular regard to the extension and localization of the lesion as judged by structural and functional investigations.
The data analyzed were: documented age at epilepsy onset, invasive EEG recordings prior to surgery, age at surgical treatment, seizure types and frequencies, disease duration, FCD location, completeness of resection in MR-positive cases (based on the postoperative MRI), postsurgical follow-up, and pharmacological treatment prior to surgery, after surgery, and at last follow-up. Patients gave informed consent to use their data for scientific purposes.
The severity of epilepsy prior to surgery was classified as severe if one of the following factors was present: daily seizures; cognitive stagnation/regression; or presence of bilateral epileptic discharges in more than 50% of the awake recordings or in more than 80% of the sleep recordings. For some statistical analysis, patients were divided into two age groups depending on their age at surgery (either at most 9 years [the middle of the age range] or above) or on their age at epilepsy onset (either younger than two years or above). Additionally, descriptive data are provided by year for interventions and outcomes depending on the age at intervention.
Magnetic-resonance imaging (MRI) was performed with 1.0, 1.5, or 3 T scanners (Siemens Magnetom Vision, Trio or Prisma, Erlangen, Germany). T1-weighted sequences with and without gadolinium-diethylenetriaminepentaacetic acid (DTPA), T2-weighted images, fluidattenuated inversion recovery (FLAIR) sequences, and MPRAGE (magnetization-prepared rapid gradient echo) sequences were performed. To analyze mesio-temporal structures, axial images with a modified angulation parallel to the long axis of the temporal lobe were acquired. Criteria used for MRI-based FCD detection were gyration anomalies, focal thickenings of the cortex, blurring of the gray-/white-matter junction, and abnormal cortical and subcortical signal intensity.
The surgical resections were classified as follows: tailored resections based not on the anatomical border of lobes but on imaging (lesionectomy) or electrophysiological findings (topectomy); unilobar resection (when the resected area followed one lobe's anatomical border); multilobar resections (when it followed several lobes' anatomical borders); and hemispherotomy (when functional disconnection was employed).
Histology
The cortical specimens of patients with FCD were classified by the Institute of Neuropathology of the University Hospital of Freiburg according to the Palmini classification [5] . Additionally, information about the presence of other epileptogenic lesions in MRI or histological specimens, i.e., hippocampal sclerosis (dual pathology), was included [11, 22, 23] .
Postoperative outcome
The postoperative seizure outcome was classified according to Engel: Ia. free of seizures; Ib. auras or seizures with drug withdrawal; II. occasional seizures (< 2 seizures/year or > 90% seizure reduction); III. 90-75% reduction of seizure frequency; IV. < 75% reduction in seizure frequency [24] ; and according to Wieser: 1. free of seizures and auras; 2. isolated auras; 3. 1-3 days with seizures per year; 4. at least four days with seizures per year or ≥50% seizure reduction; 5. < 50% seizure reduction; 6. > 100% seizure increase in comparison to preoperative frequencies [25] , as assessed at follow-up times evaluated twice yearly during the first two years and annually thereafter. For those patients who underwent surgery twice, only the last surgery was considered for outcome analysis.
Statistical analysis
Statistical analysis was done with IBM SPSS Statistics 23, MS Excel 2010, and R version 3.2.5. P-values were calculated by the chi-square test, Fisher's exact test, and Kruskal-Wallis test. All tests were two tailed, with the threshold for significance set at p < 0.05. Correlations were quantified using Pearson correlation coefficients (r) and their 95% confidence intervals (95% CI).
Results
A total of 113 patients (71 male, 42 female; mean age 10.3 years) met the inclusion criteria and were analyzed. The demographic and clinical data of the patients are summarized in Table 1 . The mean age at epilepsy onset was three years (range 0-15; median 1.5).
The duration of the disease prior to first surgery was on average 7.2 years (range 0-18; median 6.2). Fifty-five patients (49%) had a severe manifestation of epilepsy, and 58 patients (51%) had a relatively mild form; severe epilepsy was similar in children with onset of epilepsy during the first two years (30/57 severe) as compared to those with later onset (25/56 severe; differences n.s.). Forty-nine patients (43%) were investigated with invasive EEG. The mean age at surgery was 10.3 years (median 10.7; range: 0-18 years), and 16 patients (14%) underwent re-operation. The age distribution of patients with FCD undergoing resective surgery is shown in Supplementary Fig. 1 .
In 98 patients (86.7%), a dysplastic lesion was visible in the MRI. Thirty-one patients (27.4%) had an additional hippocampal sclerosis, corresponding to FCD III according to Blümcke et al. [10] .
Tailored resections (lesionectomy or topectomy, based on imaging and electrophysiological findings) were performed in 45 patients (40%); these involved only temporal areas in 12 patients (11%), while there was involvement beyond the temporal lobe (or extratemporal) in 33 patients (29%). Lobectomy was performed in 42 patients (37%); these involved the temporal lobe in 33 patients (29%) and an extratemporal lobe in nine patients (8%). A multi-lobectomy was performed in 18 patients (16%) and functional hemispherotomy in eight patients (7%). 7 of 8 hemispherotomies were performed in children under the age of seven years. Some patients with FCD with multilobar extent received a tailored resection, which could involve FCD parts in several lobes, rather than a multi-lobectomy determined by the anatomical border of the lobes. The frequency of each surgical strategy in relation to patient age at surgery is shown in Supplementary Fig. 2 .
Overall seizure outcome
The follow-up time after the last surgery ranged from 18 to 204 months (mean 67 months; median 60 months). The distribution of outcomes at various follow-up times is shown in Fig. 1 . The percentages of the various outcome categories are given relative to the number of patients available for follow-up at each time point (112 children had follow-up data for two years; 67 had follow-up for five years; 42 had follow-up for seven years; 13 had follow-up for at least 10 years).
Notably, the outcome was relatively stable, with 61% of patients achieving an Engel I or Wieser 1 or 2 outcome after five years vs. 64% after two years. Similarly, the percentage of patients not profiting from surgery (< 75% seizure reduction: Engel IV, Wiser 5) changed only from 10% at two years to 9% at five years after surgery. Longer followup periods were available only for smaller patient numbers and showed a similar trend of minor loss of efficacy over time.
Out of 69 patients who achieved seizure freedom (Engel Ia; Wieser 1) in the first year, seven deteriorated in the Engel category after two years; an additional eight patients further deteriorated in the Engel category five years after surgery, while one patient improved. Seven years after surgery, one patient deteriorated and one patient improved. After this follow-up point, no more patients deteriorated in outcome classification, whereas one patient improved after 10 years and two after 11 years. Among the patients with a visible FCD on the MRI, 52 of 98 patients (53%) were seizure free at their last follow-up, whereas five of 15 patients (33%) with a non-clear dysplastic lesion on the MRI were seizure free at their last follow-up (differences n.s.).
Patients studied with invasive EEG had outcomes similar to those of patients who were not implanted (31 patients free of seizures out of 64 patients not implanted [48%] vs. 26 patients free of seizures out of 49 patients implanted [53%] [p = 0.705] at last follow-up).
The completeness of the resection of the structural lesion was studied in 96 of the 98 patients with a visible dysplastic lesion in the MRI (in two cases, it was not possible to assess this due to a movement artifact in the postoperative MRI of one patient and inaccessibility of the MRI in the other). In 84 patients (86%), the visible lesion was completely removed, and 47 (56%) of them achieved long-term seizure freedom. In five patients (5%), the lesion was not completely removed due to an overlap of dysplastic tissue with eloquent cortex, and in seven patients (9%) it was not completely removed for other reasons. Incomplete resection led to long-term seizure freedom in four of 12 patients (33%). This difference was significant with one-sided testing, based on the hypothesis that incomplete resection leads to an inferior outcome (Fisher's exact test: p = 0.042), but only a strong trend was shown with two-sided testing (p = 0.065).
Pharmacological treatment
The majority of patients had polytherapy treatment prior to surgery (70 patients; 61.9%), while 41 patients (36.3%) were on monotherapy, and one patient (0.9%) had no AED treatment; in another patient, we had no access to drug history. At last follow-up (on average, 5.6 years after surgical treatment), 22 patients (20% of all patients and 39% of seizure-free patients) had successfully discontinued antiepileptic medication, and 25 further patients had reduced medication from polytherapy to monotherapy (25/70; 35.7%). See Fig. 2 .
Factors influencing the outcome, timing, and extent of surgery
The surgical approach was more extensive in younger patients (Mann-Whitney U test: p = 0.005); 18 of 45 (40%) of the surgeries affected more than one lobe in patients who were at most nine years old vs. 15 of 68 (22%) in patients older than nine years. Despite more limited resections, the long-term outcome at a mean follow-up of 5.6 years tended to be superior in older children; 19 of 45 (42.2%) patients aged ≤9 years experienced seizure freedom vs. 38 of 68 (55.9%) in patients older than 9 years (n.s.; Fig. 3A ).
Most patients with FCD had an onset of epilepsy in early childhood (mean age at epilepsy onset: 3.08 years), including those operated on at higher ages, representing a longer duration of epilepsy rather than a later epilepsy onset (Fig. 3B ). Age at first surgery was more strongly correlated with the duration of epilepsy (r = 0.79; 95% CI: 0.71; 0.86) than with age at epilepsy onset (r = 0.44; 95% CI: 0.31; 0.56).
Patients who experienced an earlier epilepsy onset had larger dysplastic areas on their MRIs. Hemispherical or multilobar FCD was present in 26 of 57 patients with epilepsy onset in the first two years vs. 10 of 56 patients with later onset (Fisher's exact test: p = 0.002). The surgical approach was significantly more extensive in the patients with an earlier epilepsy onset (Mann-Whitney U test: p < 0.0001). Likewise, patients who were operated on at younger ages had larger areas of FCD as measured by MRI (hemispherical or multilobar) in comparison with patients operated on later in childhood, who had more frequent unilobar involvement (temporal or extratemporal; Mann-Whitney U test: p < 0.0001); such extended FCD was present in 46% of patients operated on prior to nine years of age vs. 22% in patients older than nine years at surgery (Fig. 3C) . The epilepsy was more severe (daily seizures, cognitive stagnation/regression, or presence of bilateral epileptic discharges in more than 50% of the awake recordings or in more than 80% of the sleep recordings) in the group of patients who were operated on at younger ages (62.5% of patients who underwent surgery at nine years or younger had a severe form of epilepsy vs. 38.5% of patients operated on when older than nine years of age [Fisher's test: p = 0.014]; see Fig. 3D ).
The outcome was related to the severity of the epilepsy prior to the operation; 64% of patients with a relatively mild form of epilepsy were seizure free at the last visit vs. only 36% of those with a severe form of epilepsy (Fisher's test: p = 0.005). There was a positive correlation of FCD extent beyond one lobe and epilepsy severity (p = 0.015).
Differences between FCD subtypes
According to Palmini's classification, 59 patients (52.2%) were classified as FCD Type I and 52 patients (46%) as FCD Type II. Histological subclassification was not possible for two patients due to insufficient tissue samples. In this cohort, FCD Type I and II were both visible in the MRI in a large fraction of cases (FCD Type I: 50/59; 84.7%; FCD Type II: 46/52; 88.5%). Dual pathology was more frequently found in patients with FCD Type I (24/59 vs. 7/52; p = 0.002).
At last follow-up, 29 of 59 patients (49.2%) with FCD Type I were seizure free (Engel Ia, Wieser 1; 35 of 59 [59%] were classified as Engel I or Wieser 1 or 2), as were 27 of 52 patients (51.9%) with FCD Type II (Engel Ia, Wieser 1; 33 of 52 [63.5%] were classified as Engel I or Wieser 1 or 2). The differences were not significant.
In patients with FCD Type I, lobectomy was the most frequent surgical approach (30/59 patients), while in patients with FCD Type II, tailored resections were more frequently performed (26/52 patients; p = 0.007).
Age at epilepsy onset and duration of epilepsy did not show significant differences between the histological subtypes. For the specific number of patients of each subgroup, see Table 1 .
Outcome with respect to surgical strategy and subtype of malformation
Outcomes tended to be better with smaller resections. Twenty-five out of 45 patients treated with a tailored resection achieved seizure freedom (55.5%), while the numbers were 21 of 42 for patients treated with uni-lobectomy (50%), seven of 18 for patients treated with multi- At last follow-up (mean 67 month), only 15% of the patients with FCD type I (28% of those seizure-free) discontinued successfully the pharmacological treatment and 25% (28% of those seizure-free) were switched from polytherapy to monotherapy, while from the patients with FCD type II 29% (48% of those seizure-free) discontinued successfully the pharmacological treatment, whereas 17% patients switched from polytherapy to monotherapy (22% of those seizure-free). lobectomy (39%), and four of eight (50%) for patients treated with hemispherotomy (differences n.s.).
While seizure freedom in FCD I was most frequently achieved using lobectomy, it was most frequent in FCD II when tailored resections were used (lesionectomies/topectomies). In FCD Type I, 16 of 30 achieved seizure freedom with lobectomy (53.3%) vs. eight of 18 (44.4%) with a tailored resection (p = 0.77). In FCD Type II, 16 of 26 (61.5%) achieved seizure freedom with tailored resections vs. five of 12 (41.7%) with lobectomy (p = 0.307). Notably, with either FCD subtype, there were cases of failed surgery even with extended resections, such as multilobectomy ( Fig. 4 ).
Recurrence rates
In the complete cohort, 12 patients (10%) experienced seizure relapse in the later postoperative course after a minimum seizure-free time of two years following surgery, with similar percentages in FCD I and II (seven of 59 patients with FCD Type I vs. five of 52 patients with FCD Type II [p = 0.765]; see Supplementary Fig. 5 ). Fig. 3 . A. Outcome in the last follow-up with respect to age at surgery. The long-term outcome for a mean of 5.6 years of follow-up tended to be superior in older children. B. Relation between epilepsy duration and the age at surgery. Children who were operated at older ages had longer duration of epilepsy rather than a later epilepsy onset. C. Box plot illustrating the differences for age at surgery in patients with unilobar (temporal and extratemporal), multilobar and hemispherical FCD. The box represents the 25th-75th percentile. Age at surgery was older for smaller types of FCD. D. Severity of epilepsy respect to age at surgery. The patients operated ≤9 years had a more severe form of epilepsy. 
Discussion
To our knowledge, this is the largest cohort of children with a longterm follow-up of 1.5-17 years after surgery for pharmacoresistant structural epilepsy caused by FCD. The vast majority of patients who achieved initial seizure freedom remained free of seizures in the longterm perspective. Over a mean follow-up period of 5.6 years, only minor changes in outcome occurred (< 10%; see Supplementary  Fig. 5 ), and the recurrence rate after two years of seizure freedom was low (10%). These results confirm surgical treatment of FCD as a highly effective therapy to achieve seizure freedom, which may offer the prerequisites for better cognitive development and social integration of pediatric patients [4, 26, 27] .
While, in our cohort, patients with FCD Type I were more frequently affected by dual pathology than patients with FCD Type II, the surgical outcomes of the FCD I subgroup were not significantly different from those of the whole cohort (Table 1) . Previous works reported similar or even higher percentages of patients achieving seizure freedom in cases with dual pathology [28] , but the significance and the epileptogenicity of the additional lesions remain unknown.
Some analyses have reported FCD II to be present at a younger age and more frequently with extratemporal and multilobar localization than FCD I [13, 29] . Data from this patient cohort are partially in accordance with this observation but suggest that the extension of FCD critically affects the timing of surgery, as noted by Cepeda et al. [29] .
In the present series, detectability of FCD in an MRI was only slightly higher in FCD Type II than in Type I, in contrast to previous studies [5] that reported lesions compatible with FCD II being more frequently identified on MRIs than lesions compatible with Type I. This may be due to advances in imaging quality but may also represent an enrichment bias, as patients with MR-visible lesions have a better chance of being selected for epilepsy surgery than non-lesional cases. As MRI is one of the main preoperative methods for defining the extent of the resection, this could also explain why resections are more limited in FCD Type II (which is more often treated by tailored resections) than in FCD I (for which the preferred surgical approach was lobectomy). Overall, our patients received more tailored resections than in other published series [30] .
In agreement with other reports [31] , patients with a visible dysplastic lesion in the MRI tended to achieve seizure freedom only marginally more frequently (52/98) than those without visible dysplastic lesion in the MRI (5/15; difference n.s.).
We did not find significant outcome differences between patients with or without intracranial EEG evaluation. This may be due to the heterogeneity of the factors that influence whether patients undergo intracranial recordings: lack of concordant information on the localization of seizure origin from at least two independent lines of evidence (e.g., MRI or PET and EEG); discordant information between video-EEG assessment and imaging; proximity and possible overlap of the suspected epileptogenic area and eloquent cortex; and sufficient age (> 3 years).
We found a higher rate of successful drug discontinuation in patients with FCD Type II. It must be acknowledged, however, that in our patient series there was no uniform strategy for continuing or discontinuing AED treatment following surgery. Thus, keeping patients on AEDs may rather reflect parents' and doctors' preferences rather than an objective finding that the remaining medication is needed to keep patients seizure free [32, 33] .
Variables such as age at seizure onset, duration of the disease, extent of the lesion in the MRI, use of invasive monitoring, extent of surgery, and histopathology features were not associated with seizure outcome in the present study, in line with other published series [13, 19, 34] . In other studies, the best outcomes of surgical interventions in patients with FCD were reported to result from hemispherotomy [35] . We found similarly good outcomes with more restricted resections. In particular, there was no general trend of more extended resections resulting in better control of seizures; tailored resections had the highest success rate overall, particularly in FCD Type II; in FCD Type I, seizure-free patients had most often received lobectomies. The results from our cohort thus suggest that-depending on the possibility of delineating the dysplastic cortical area-a tailored approach is adequate for a substantial proportion of children with FCD-related epilepsy.
Interestingly, in the cohort studied here, earlier resections were frequently more extended than later resections, whereas there is a tendency for better outcomes with later, more frequently tailored resections. This is of practical interest for the timing of epilepsy surgery Fig. 4 . Outcomes in the last follow-up depending on the surgical strategy in patients with FCD type I (left graph) and FCD type II (right graph). Whereas seizure freedom in FCD I was most frequently achieved using lobectomy, it was most frequent in FCD II with tailored resections. [37] . In a group of pediatric patients, Dunkley et al. [38] found no change in the developmental trajectory of children undergoing surgery, even when they achieved seizure freedom. They suggest that differences in outcome in children undergoing surgery at various ages may be due to the diverse underlying pathologies and procedures rather than being related merely to the age of the patients. In our cohort, the decision for early surgery was based on the severity of the epilepsy, with frequent daily seizures, cognitive stagnation or regression, or electrographic signs of encephalopathy found in those undergoing early surgery. Also, the extent of the dysplasia in the MRI was larger (hemispherical or multilobar) in patients who underwent surgery at younger ages than in patients who were older at the time of surgery, in agreement with a previous report by Cepeda [29] . This study is limited by its retrospective character and by the assessment of a limited cohort of children with FCD undergoing epilepsy surgery in childhood.
Although it is the largest cohort reported during childhood, larger patient collectives may allow for the conducting of further sub-analyses of stratified subgroups. The even distribution of FCD I and II and the distribution over the whole range of ages at surgery did, however, allow for the first sub-analyses regarding outcome and resective approach, which may serve as a basis for future multicentric analyses. Additional consideration of cognitive performance in the course of the disease may provide complementary information relevant to therapeutic decisions.
Conclusion
Given the more difficult delineation of lesions in early childhood (related to the incomplete maturation of gray-/white-matter boundaries; an example is shown in Supplementary Fig. 6 ) and the better outcome achieved with more local resections performed in children of greater age, the decision regarding the timing of surgical intervention may not follow a simple strategy of "the earlier the better." Our data rather suggest that in patients with poorly visible MRI lesions or an unclear extent of the dysplastic area, a later resection may offer advantages in terms of selectivity and the precision of the surgical resection planning. Certainly, additional factors such as an epileptic encephalopathy and drug tolerability also have to be taken into consideration when weighing arguments in favor of earlier or later surgical intervention (see Table 2 ). In patients lacking evidence of a lesion on the MRI, delaying a surgical decision may offer advantages regarding the localizing value of semiology and electroencephalographic features. Finally, the decision about timing must also take into consideration the negative effects of uncontrolled epilepsy on social and cognitive development, which may argue in favor of early interventions. 
